Cargando…

A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients

Objectives: We attempted to develop more precisely quantified risk models for predicting cardiogenic stroke risk in non-valvular atrial fibrillation (NVAF) patients. Methods: We conducted a case-control study, using data from hospitalized patients with AF who underwent transesophageal echocardiograp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Ziliang, Xu, Kai, Hu, Xiaofeng, Jiang, Weifeng, Wu, Shaohui, Qin, Mu, Liu, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683797/ https://www.ncbi.nlm.nih.gov/pubmed/33244472 http://dx.doi.org/10.3389/fcvm.2020.604795

Ejemplares similares

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2021)

Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation
por: Liu, Ya-ou, et al.
Publicado: (2022)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Right atrial appendage: an important structure to drive atrial fibrillation
por: Liu, Yang, et al.
Publicado: (2022)

Nomogram to Predict Left Atrial Thrombus or Spontaneous Echo Contrast in Patients With Non-valvular Atrial Fibrillation
por: Li, Zhitong, et al.
Publicado: (2021)

Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China
por: Shi, Shaobo, et al.
Publicado: (2022)

Left atrial epicardial adipose tissue is associated with low voltage zones in the left atrium in patients with non-valvular atrial fibrillation
por: Shao, Yameng, et al.
Publicado: (2022)

Clinical Safety and Efficacy of Ablation for Atrial Fibrillation Patients With a History of Stroke
por: Song, Zi-liang, et al.
Publicado: (2021)

Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation
por: Wang, Hua, et al.
Publicado: (2022)

The value of left atrial longitudinal strain in evaluating left atrial appendage spontaneous echo contrast in non-valvular atrial fibrillation
por: Ma, Chang sheng, et al.
Publicado: (2023)

Economic and Clinical Impact of Stroke and Warfarin Use for Patients with Non-valvular Atrial Fibrillation
por: Wang, Li, et al.
Publicado: (2013)

Efficacy and safety evaluation of rivaroxaban vs. warfarin among non-valvular atrial fibrillation patients undergoing lower extremity revascularization
por: Yu, Qingyuan, et al.
Publicado: (2022)

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases
por: Zhu, Xiyu, et al.
Publicado: (2020)

Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
por: Johnson, Michelle E, et al.
Publicado: (2016)

Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

Incidence of atrial functional tricuspid regurgitation and its correlation with tricuspid valvular deformation in patients with persistent atrial fibrillation
por: Yamamoto, Yuko, et al.
Publicado: (2022)

Quantitative acetylated proteomics on left atrial appendage tissues revealed atrial energy metabolism and contraction status in patients with valvular heart disease with atrial fibrillation
por: Tu, Tao, et al.
Publicado: (2022)

A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk
por: Liu, Peng-Hui, et al.
Publicado: (2022)

Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis
por: Yang, Zhenzhen, et al.
Publicado: (2023)

Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study
por: Gao, Jie, et al.
Publicado: (2022)

Comparative analysis of left atrial appendage closure efficacy and outcomes by CHA(2)DS(2)-VASc score group in patients with non-valvular atrial fibrillation
por: Zhao, Mingzhong, et al.
Publicado: (2022)

Integrative Analysis Reveals Key Circular RNA in Atrial Fibrillation
por: Hu, Xiaofeng, et al.
Publicado: (2019)

Machine learning-based analysis of risk factors for atrial fibrillation recurrence after Cox-Maze IV procedure in patients with atrial fibrillation and chronic valvular disease: A retrospective cohort study with a control group
por: Jiang, Zenan, et al.
Publicado: (2023)

Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
por: Rubio-Terrés, Carlos, et al.
Publicado: (2016)

The safety and efficacy of direct oral anticoagulants among chronic kidney disease patients on dialysis with non-valvular atrial fibrillation: a meta-analysis
por: Mapili, Jerahmeel Aleson L., et al.
Publicado: (2023)

A novel approach for quantitative electrogram analysis for driver identification: Implications for ablation in persistent atrial fibrillation
por: Shi, Wen-Rui, et al.
Publicado: (2022)

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry
por: Camm, A John, et al.
Publicado: (2017)

Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
por: Wu, Jia, et al.
Publicado: (2020)

Radiofrequency ablation for paroxysmal atrial fibrillation in a patient with dextrocardia and interruption of the inferior vena cava: a case report
por: Hu, Xiaofeng, et al.
Publicado: (2021)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2022)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

A New Vision at the Interface of Atrial Fibrillation and Stroke
por: Ronsoni, Rafael M., et al.
Publicado: (2021)

Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nationwide cohort study
por: Wu, Hsin-Hsu, et al.
Publicado: (2022)

Combination of platelet-to-lymphocyte ratio and D-dimer for the identification of cardiogenic cerebral embolism in non-valvular atrial fibrillation
por: Shi, Yachen, et al.
Publicado: (2023)

Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial
por: Sotomi, Yohei, et al.
Publicado: (2021)

Stroke risk evaluation for patients with atrial fibrillation: Insights from left atrial appendage
por: Fang, Runxin, et al.
Publicado: (2022)

Effect of Preablation Glycemic Control on Outcomes of Atrial Fibrillation Patients With Diabetes Mellitus Following Valvular Surgery Combined With the Cox-Maze IV Procedure
por: Peng, Zhan, et al.
Publicado: (2022)

Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke
por: Qureshi, Ahmed, et al.
Publicado: (2023)

Searching for atrial fibrillation post stroke: is it time for digital devices?
por: Piot, Olivier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uirj3ipu19c992p6oc8v3a528h